Targeting VCAM-1: a therapeutic opportunity for vascular damage

References

• Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American heart association. Circulation. 2022 Feb 22;145(8):e153–e639.
   Google Scholar
• World Health Organization (WHO). Cardiovascular diseases (CVDs). https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds) 2022 [updated 2022]
   Google Scholar
• Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res. 2005 Sep 16;97(6):512–523.
   PubMed Web of Science ®Google Scholar
• Seidelmann SB, Lighthouse JK, Greif DM. Development and pathologies of the arterial wall. Cell Mol Life Sci. 2014 Jun;71(11):1977–1999.
   PubMed Web of Science ®Google Scholar
• Troncoso MF, Ortiz-Quintero J, Garrido-Moreno V, et al. VCAM-1 as a predictor biomarker in cardiovascular disease. Biochim Biophys Acta Mol Basis Dis. 2021 Sep 1;1867(9):166170.
   PubMed Web of Science ®Google Scholar
• Madri JA, Graesser D, Haas T. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. Biochem Cell Biol. 1996;74(6):749–757.
   PubMed Web of Science ®Google Scholar
• Cook-Mills JMVCAM-1. signals during lymphocyte migration: role of reactive oxygen species. Mol Immunol. 2002 Dec;39(9):499–508.
   PubMed Web of Science ®Google Scholar
• Couffinhal T, Duplaa C, Moreau C, et al. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res. 1994 Feb;74(2):225–234.
   PubMed Web of Science ®Google Scholar
• Gamble JR, Bradley S, Noack L, et al. TGF-beta and endothelial cells inhibit VCAM-1 expression on human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1995 Jul;15(7):949–955.
   PubMed Web of Science ®Google Scholar
• O’Brien KD, Allen MD, McDonald TO, et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 1993 Aug;92(2):945–951.
   PubMed Web of Science ®Google Scholar
• Kong DH, Kim YK, Kim MR, et al. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. Int J Mol Sci. 2018 2 Apr;19(4)
   Web of Science ®Google Scholar
• Galkina E, Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2292–2301.
   PubMed Web of Science ®Google Scholar
• Summitt JB, Chan DC, Burgess JO, et al. Effect of air/water rinse versus water only and of five rinse times on resin-to-etched-enamel shear bond strength. Oper Dent. 1992 Jul-Aug;17(4):142–151.
   PubMed Web of Science ®Google Scholar
• Cook-Mills JM, Marchese ME, Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid Redox Signal. 2011 Sep 15; 15(6):1607–1638.
   PubMed Web of Science ®Google Scholar
• Varela ML, Mogildea M, Moreno I, et al. Acute inflammation and metabolism. Inflammation. 2018 Aug;41(4):1115–1127.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008 Jul 24;454(7203):428–435.
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Davis V, Li H, et al. Targeted disruption of the murine VCAM1 gene: essential role of VCAM-1 in chorioallantoic fusion and placentation. Genes Dev. 1995 Jan 1;9(1):1–14.
   PubMed Web of Science ®Google Scholar
• Kwee L, Baldwin HS, Shen HM, et al. Defective development of the embryonic and extraembryonic circulatory systems in vascular cell adhesion molecule (VCAM-1) deficient mice. Development. 1995 Feb;121(2):489–503.
   PubMed Web of Science ®Google Scholar
• The Human Protein Atlas 2023. [cited 2023 Jan 10]. Available from: https://www.proteinatlas.org/ENSG00000162692-VCAM1/tissue
   Google Scholar
• Eelen G, de Zeeuw P, Treps L, et al. Endothelial cell metabolism. Physiol Rev. 2018 Jan 1;98(1):3–58.
   PubMed Web of Science ®Google Scholar
• Augustin HG, Kozian DH, Johnson RC. Differentiation of endothelial cells: analysis of the constitutive and activated endothelial cell phenotypes. Bioessays. 1994 Dec;16(12):901–906.
   PubMed Web of Science ®Google Scholar
• Shao Y, Cheng Z, Li X, et al. Immunosuppressive/anti-inflammatory cytokines directly and indirectly inhibit endothelial dysfunction–a novel mechanism for maintaining vascular function. J Hematol Oncol. 2014 Oct;31(7):80.
   Google Scholar
• Moncada S, Higgs EA. Nitric oxide and the vascular endothelium. Handb Exp Pharmacol. 2006;176/I(176 Pt 1):213–254.
   Google Scholar
• Davidson SM. Endothelial mitochondria and heart disease. Cardiovasc Res. 2010 Oct 1;88(1):58–66.
   PubMed Web of Science ®Google Scholar
• Majewska E, Paleolog E, Baj Z, et al. Role of tyrosine kinase enzymes in TNF-alpha and IL-1 induced expression of ICAM-1 and VCAM-1 on human umbilical vein endothelial cells. Scand J Immunol. 1997 Apr;45(4):385–392.
   PubMed Web of Science ®Google Scholar
• Tamaru M, Tomura K, Sakamoto S, et al. Interleukin-1beta induces tissue- and cell type-specific expression of adhesion molecules in vivo. Arterioscler Thromb Vasc Biol. 1998 Aug;18(8):1292–1303.
   PubMed Web of Science ®Google Scholar
• Zhong Y, He S, Huang K, et al. Neferine suppresses vascular endothelial inflammation by inhibiting the NF-kappaB signaling pathway. Arch Biochem Biophys. 2020 Dec;15(696):108595.
   Google Scholar
• O’Keeffe LM, Muir G, Piterina AV, et al. Vascular cell adhesion molecule-1 expression in endothelial cells exposed to physiological coronary wall shear stresses. J Biomech Eng. 2009 Aug;131(8):081003.
   PubMed Web of Science ®Google Scholar
• Chiu JJ, Lee PL, Chen CN, et al. Shear stress increases ICAM-1 and decreases VCAM-1 and E-selectin expressions induced by tumor necrosis factor-[alpha] in endothelial cells. Arterioscler Thromb Vasc Biol. 2004 Jan;24(1):73–79.
   PubMed Web of Science ®Google Scholar
• Korenaga R, Ando J, Kosaki K, et al. Negative transcriptional regulation of the VCAM-1 gene by fluid shear stress in murine endothelial cells. Am J Physiol. 1997 Nov;273(5 Pt 1):C1506–15.
   PubMedGoogle Scholar
• Matheny HE, Deem TL, Cook-Mills JM. Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase. J Immunol. 2000 Jun 15;164(12):6550–6559.
   PubMed Web of Science ®Google Scholar
• Berdnikovs S, Abdala-Valencia H, Cook-Mills JM. Endothelial cell PTP1B regulates leukocyte recruitment during allergic inflammation. Am J Physiol Lung Cell Mol Physiol. 2013 Feb 15;304(4):L240–9.
   PubMed Web of Science ®Google Scholar
• Cook-Mills JM, Johnson JD, Deem TL, et al. Calcium mobilization and Rac1 activation are required for VCAM-1 (vascular cell adhesion molecule-1) stimulation of NADPH oxidase activity. Biochem J. 2004 Mar 1;378(Pt 2):539–547.
   PubMedGoogle Scholar
• Deem TL, Cook-Mills JM. Vascular cell adhesion molecule 1 (VCAM-1) activation of endothelial cell matrix metalloproteinases: role of reactive oxygen species. Blood. 2004 Oct 15;104(8):2385–2393.
   PubMed Web of Science ®Google Scholar
• Deem TL, Abdala-Valencia H, Cook-Mills JM. VCAM-1. activation of endothelial cell protein tyrosine phosphatase 1B. J Immunol. 2007 Mar 15;178(6):3865–3873.
   PubMed Web of Science ®Google Scholar
• Le Bras M, Clement MV, Pervaiz S, et al. Reactive oxygen species and the mitochondrial signaling pathway of cell death. Histol Histopathol. 2005 Jan;20(1):205–219.
   PubMed Web of Science ®Google Scholar
• Gutteridge JM. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem. 1995 Dec;41(12 Pt 2):1819–1828.
   PubMed Web of Science ®Google Scholar
• Gutteridge JM, Mitchell J. Redox imbalance in the critically ill. Br Med Bull. 1999;55(1):49–75.
   PubMed Web of Science ®Google Scholar
• Toborek M, Kaiser S. Endothelial cell functions Relationship to atherogenesis. Basic Res Cardiol. 1999 Oct;94(5):295–314.
   PubMed Web of Science ®Google Scholar
• Ferri C, Grassi D. Antioxidants and beneficial microvascular effects: is this the remedy? Hypertension. 2010 Jun;55(6):1310–1311.
   PubMed Web of Science ®Google Scholar
• Mitra S, Deshmukh A, Sachdeva R, et al. Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy. Am J Med Sci. 2011 Aug;342(2):135–142.
   PubMed Web of Science ®Google Scholar
• Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: part I: basic mechanisms and in vivo monitoring of ROS. Circulation. 2003 Oct 21;108(16):1912–1916.
   PubMed Web of Science ®Google Scholar
• Jiang H, Zhou Y, Nabavi SM, et al. Mechanisms of oxidized LDL-mediated endothelial dysfunction and its consequences for the development of atherosclerosis. Front Cardiovasc Med. 2022;9:925923.
   PubMed Web of Science ®Google Scholar
• Mackay F, Loetscher H, Stueber D, et al. Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J Exp Med. 1993 May 1;177(5):1277–1286.
   PubMed Web of Science ®Google Scholar
• Yoshida N, Manabe H, Terasawa Y, et al. Inhibitory effects of vitamin E on endothelial-dependent adhesive interactions with leukocytes induced by oxidized low density lipoprotein. Biofactors. 2000;13(1–4):279–288.
   PubMed Web of Science ®Google Scholar
• Lee YW, Kuhn H, Hennig B, et al. IL-4-induced oxidative stress upregulates VCAM-1 gene expression in human endothelial cells. J Mol Cell Cardiol. 2001 Jan;33(1):83–94.
   PubMed Web of Science ®Google Scholar
• van Wetering S, van den Berk N, van Buul JD, et al. VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am J Physiol Cell Physiol. 2003 Aug;285(2):C343–52.
   PubMed Web of Science ®Google Scholar
• Liu H, Jia K, Ren Z, et al. PRMT5 critically mediates TMAO-induced inflammatory response in vascular smooth muscle cells. Cell Death Dis. 2022 Apr 4;13(4):299.
   PubMed Web of Science ®Google Scholar
• Kim SR, Bae YH, Bae SK, et al. Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta. 2008 May;1783(5):886–895.
   PubMed Web of Science ®Google Scholar
• Salvayre R, Negre-Salvayre A, Camare C. Oxidative theory of atherosclerosis and antioxidants. Biochimie. 2016 Jun;125:281–296.
   PubMed Web of Science ®Google Scholar
• Wagner AH, Kautz O, Fricke K, et al. Upregulation of glutathione peroxidase offsets stretch-induced proatherogenic gene expression in human endothelial cells. Arterioscler Thromb Vasc Biol. 2009 Nov;29(11):1894–1901.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li J, Hartstone-Rose A, et al. Chinese herbal compounds for the prevention and treatment of atherosclerosis: experimental evidence and mechanisms. Evid Based Complement Alternat Med. 2015;2015:752610.
   PubMed Web of Science ®Google Scholar
• Malekmohammad K, Sewell RDE, Antioxidants R-KM. Atherosclerosis: mechanistic Aspects. Biomolecules. 2019 Jul 25;9:8.
   Web of Science ®Google Scholar
• Yin L, Bai J, Wj Y, et al. Blocking VCAM-1 prevents angiotensin II-induced hypertension and vascular remodeling in mice. Front Pharmacol. 2022;13:825459.
   PubMed Web of Science ®Google Scholar
• Chothia C, Jones EY. The molecular structure of cell adhesion molecules. Annu Rev Biochem. 1997;66:823–862.
   PubMed Web of Science ®Google Scholar
• Umetani M, Nakao H, Doi T, et al. A novel cell adhesion inhibitor, K-7174, reduces the endothelial VCAM-1 induction by inflammatory cytokines, acting through the regulation of GATA. Biochem Biophys Res Commun. 2000 Jun 7;272(2):370–374.
   PubMed Web of Science ®Google Scholar
• Umetani M, Mataki C, Minegishi N, et al. Function of GATA transcription factors in induction of endothelial vascular cell adhesion molecule-1 by tumor necrosis factor-alpha. Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):917–922.
   PubMed Web of Science ®Google Scholar
• Takano Y, Hiramatsu N, Okamura M, et al. Suppression of cytokine response by GATA inhibitor K-7174 via unfolded protein response. Biochem Biophys Res Commun. 2007 Aug 24;360(2):470–475.
   PubMed Web of Science ®Google Scholar
• Lee S, Yoon IH, Yoon A, et al. An antibody to the sixth Ig-like domain of VCAM-1 inhibits leukocyte transendothelial migration without affecting adhesion. J Immunol. 2012 Nov 1;189(9):4592–4601.
   PubMed Web of Science ®Google Scholar
• Kim TK, Park CS, Na HJ, et al. Ig-like domain 6 of VCAM-1 is a potential therapeutic target in TNFalpha-induced angiogenesis. Exp Mol Med. 2017 Feb 17;49(2):e294.
   PubMedGoogle Scholar
• Shi N, Mei X, Chen SY. Smooth Muscle Cells in Vascular Remodeling. Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):e247–e252.
   PubMed Web of Science ®Google Scholar
• Campbell JH, Campbell GR. Smooth muscle phenotypic modulation–a personal experience. Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):1784–1789.
   PubMed Web of Science ®Google Scholar
• Li H, Cybulsky MI, Gimbrone MA Jr., et al. Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am J Pathol. 1993 Dec;143(6):1551–1559.
   PubMed Web of Science ®Google Scholar
• Wang X, Feuerstein GZ, Gu JL, et al. Interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells. Atherosclerosis. 1995 May;115(1):89–98.
   PubMed Web of Science ®Google Scholar
• Alzamil H. Elevated serum TNF-alpha is related to obesity in type 2 diabetes mellitus and is associated with glycemic control and insulin resistance. J Obes. 2020;2020:5076858.
   PubMed Web of Science ®Google Scholar
• Wang TT, Wang XM, Zhang XL. Circulating vascular cell adhesion molecule-1 (VCAM-1) and intercellular Adhesion Molecule-1 (ICAM-1): relationship with carotid artery elasticity in patients with impaired glucose regulation (IGR). Ann Endocrinol (Paris). 2019 Apr;80(2):72–76.
   PubMed Web of Science ®Google Scholar
• Tummala PE, Chen XL, Sundell CL, et al. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation. 1999 Sep 14;100(11):1223–1229.
   PubMed Web of Science ®Google Scholar
• Hsu CY, Vo TTT, Lee CW, et al. Carbon monoxide releasing molecule-2 attenuates angiotensin II-induced IL-6/Jak2/Stat3-associated inflammation by inhibiting NADPH oxidase- and mitochondria-derived ROS in human aortic smooth muscle cells. Biochem Pharmacol. 2022;Apr 198 114978.
   PubMed Web of Science ®Google Scholar
• Lv P, Yin YJ, Kong P, et al. SM22alpha loss contributes to apoptosis of vascular smooth muscle cells via macrophage-derived circRasGEF1B. Oxid Med Cell Longev. 2021;2021:5564884.
   PubMed Web of Science ®Google Scholar
• Chen L, Frister A, Wang S, et al. Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production. Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H987–96.
   PubMed Web of Science ®Google Scholar
• Wang S, Shi M, Li J, et al. Endothelial cell-derived exosomal circHIPK3 promotes the proliferation of vascular smooth muscle cells induced by high glucose via the miR-106a-5p/Foxo1/Vcam1 pathway. Aging (Albany NY). 2021 Dec 10;13(23):25241–25255.
   PubMedGoogle Scholar
• Liu Q, Yang M, Zhang L, et al. Metformin inhibits cholesterol‑induced adhesion molecule expression via activating the AMPK signaling pathway in vascular smooth muscle cells. Mol Med Rep. 2021;24(4):709.
   PubMed Web of Science ®Google Scholar
• Wang G, Jacquet L, Karamariti E, et al. Origin and differentiation of vascular smooth muscle cells. J Physiol. 2015 Jul 15;593(14):3013–3030.
   PubMed Web of Science ®Google Scholar
• Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004 Jul;84(3):767–801.
   PubMed Web of Science ®Google Scholar
• Sorokin V, Vickneson K, Kofidis T, et al. Role of vascular smooth muscle cell plasticity and interactions in vessel wall inflammation. Front Immunol. 2020;11:599415.
   PubMed Web of Science ®Google Scholar
• Yan Y, Zhu M, Ma J, et al. MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis. Bioengineered. 2022 Apr;13(4):11214–11227.
   PubMed Web of Science ®Google Scholar
• Li J, Wang C, Wang W, et al. PRDX2 protects against atherosclerosis by regulating the phenotype and function of the vascular smooth muscle cell. Front Cardiovasc Med. 2021;8:624796.
   PubMed Web of Science ®Google Scholar
• Petersen EJ, Miyoshi T, Yuan Z, et al. siRNA silencing reveals role of vascular cell adhesion molecule-1 in vascular smooth muscle cell migration. Atherosclerosis. 2008 Jun;198(2):301–306.
   PubMed Web of Science ®Google Scholar
• Thayse K, Kindt N, Laurent S, et al. VCAM-1 Target in Non-Invasive Imaging for the Detection of Atherosclerotic Plaques. Biology (Basel), 29 Oct 2020;9(11):368.
   PubMedGoogle Scholar
• Ramji DP, Davies TS. Cytokines in atherosclerosis: key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev. 2015 Dec;26(6):673–685.
   PubMed Web of Science ®Google Scholar
• Delporte C, Van Antwerpen P, Vanhamme L, et al. Low-density lipoprotein modified by myeloperoxidase in inflammatory pathways and clinical studies. Mediators Inflamm. 2013;2013:971579.
   PubMed Web of Science ®Google Scholar
• Davies MJ, Gordon JL, Gearing AJ, et al. The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993 Nov;171(3):223–229.
   PubMed Web of Science ®Google Scholar
• Moriya J. Critical roles of inflammation in atherosclerosis. J Cardiol. 2019 Jan;73(1):22–27.
   PubMed Web of Science ®Google Scholar
• Cybulsky MI, Iiyama K, Li H, et al. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J Clin Invest. 2001 May;107(10):1255–1262.
   PubMed Web of Science ®Google Scholar
• Iiyama K, Hajra L, Iiyama M, et al. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation. Circ Res. 1999 Jul 23;85(2):199–207.
   PubMed Web of Science ®Google Scholar
• Sun HJ, Zhao MX, Liu TY, et al. Salusin-beta induces foam cell formation and monocyte adhesion in human vascular smooth muscle cells via miR155/NOX2/NFkappaB pathway. Sci Rep. 2016 Mar 23;6:23596.
   PubMed Web of Science ®Google Scholar
• Mu W, Chen M, Gong Z, et al. Expression of vascular cell adhesion molecule-1 in the aortic tissues of atherosclerotic patients and the associated clinical implications. Exp Ther Med. 2015 Aug;10(2):423–428.
   PubMed Web of Science ®Google Scholar
• Cuff CA, Kothapalli D, Azonobi I, et al. The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation. J Clin Invest. 2001 Oct;108(7):1031–1040.
   PubMed Web of Science ®Google Scholar
• Watanabe T, Nishio K, Kanome T, et al. Impact of salusin-alpha and -beta on human macrophage foam cell formation and coronary atherosclerosis. Circulation. 2008 Feb 5;117(5):638–648.
   PubMed Web of Science ®Google Scholar
• Arkan A, Atukeren P, Ikitimur B, et al. The importance of circulating levels of salusin-alpha, salusin-beta, and heregulin-beta1 in atherosclerotic coronary arterial disease. Clin Biochem. 2021;Jan 87 19–25.
   PubMed Web of Science ®Google Scholar
• Abela GS, Kalavakunta JK, Janoudi A, et al. Frequency of cholesterol crystals in culprit coronary artery aspirate during acute myocardial infarction and their relation to inflammation and myocardial injury. Am J Cardiol. 2017 Nov 15;120(10):1699–1707.
   PubMed Web of Science ®Google Scholar
• Kataoka Y, Puri R, Hammadah M, et al. Cholesterol crystals associate with coronary plaque vulnerability in vivo. J Am Coll Cardiol. 2015 Feb 17;65(6):630–632.
   PubMed Web of Science ®Google Scholar
• Pichavaram P, Mani AM, Singh NK, et al. Cholesterol crystals promote endothelial cell and monocyte interactions via H2O2-mediated PP2A inhibition, NFkappaB activation and ICAM1 and VCAM1 expression. Redox Biol. 2019;Jun 24 101180.
   PubMed Web of Science ®Google Scholar
• Sedding DG, Boyle EC, Demandt JAF, et al. Vasa vasorum angiogenesis: key player in the initiation and progression of atherosclerosis and potential target for the treatment of cardiovascular disease. Front Immunol. 2018;9:706.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003 Jun;9(6):669–676.
   PubMed Web of Science ®Google Scholar
• Fearnley GW, Odell AF, Latham AM, et al. VEGF-A isoforms differentially regulate ATF-2-dependent VCAM-1 gene expression and endothelial-leukocyte interactions. Mol Biol Cell. 2014 Aug 15;25(16):2509–2521.
   PubMed Web of Science ®Google Scholar
• Death AK, McGrath KC, Sader MA, et al. Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway. Endocrinology. 2004 Apr;145(4):1889–1897.
   PubMed Web of Science ®Google Scholar
• Ludwig A, Fechner M, Wilck N, et al. Potent anti-inflammatory effects of low-dose proteasome inhibition in the vascular system. J Mol Med (Berl). 2009 Aug;87(8):793–802.
   PubMed Web of Science ®Google Scholar
• Wilck N, Fechner M, Dreger H, et al. Attenuation of early atherogenesis in low-density lipoprotein receptor-deficient mice by proteasome inhibition. Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1418–1426.
   PubMed Web of Science ®Google Scholar
• Wilck N, Fechner M, Dan C, et al. The effect of low-dose proteasome inhibition on pre-existing atherosclerosis in LDL receptor-deficient mice. Int J Mol Sci. 2017 7 Apr; 18(4).
   PubMed Web of Science ®Google Scholar
• Ismawati I, Romus I, Mukhyarjon M, et al. Effect of proteasome inhibitor on vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) expressions in rat model of atherosclerosis. Rep Biochem Mol Biol. 2022 Jan;10(4):633–639.
   PubMed Web of Science ®Google Scholar
• Chu L-Y, Hsueh Y-C, Cheng H-L, et al. Cytokine-induced autophagy promotes long-term VCAM-1 but not ICAM-1 expression by degrading late-phase IκBα. Sci Rep. 2017 Sep 29;7(1):12472.
   PubMedGoogle Scholar
• Grimaldi V, Vietri MT, Schiano C, et al. Epigenetic reprogramming in atherosclerosis. Curr Atheroscler Rep. 2015;17(2):476.
   PubMed Web of Science ®Google Scholar
• Napoli C, Crudele V, Soricelli A, et al. Primary prevention of atherosclerosis: a clinical challenge for the reversal of epigenetic mechanisms? Circulation. 2012 May 15;125(19):2363–2373.
   PubMed Web of Science ®Google Scholar
• Manea SA, Vlad ML, Fenyo IM, et al. Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis. Redox Biol. 2020;Jan 28 101338.
   PubMed Web of Science ®Google Scholar
• Kulthinee S, Yano N, Zhuang S, et al. Critical functions of histone deacetylases (HDACS) in modulating inflammation associated with cardiovascular diseases. Pathophysiology. 2022 Aug 22;29(3):471–485.
   PubMedGoogle Scholar
• Hu C, Peng K, Wu Q, et al. HDAC1 and 2 regulate endothelial VCAM-1 expression and atherogenesis by suppressing methylation of the GATA6 promoter. Theranostics. 2021;11(11):5605–5619.
   PubMed Web of Science ®Google Scholar
• Liu S, Gao J, Wang S. HOXA9 inhibitors promote microcirculation of coronary arteries in rats via downregulating E-selectin/VCAM-1. Exp Ther Med. 2021 Aug;22(2):871.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Ramos S, Paz-Garcia M, Rius C, et al. Endothelial NOD1 directs myeloid cell recruitment in atherosclerosis through VCAM-1. FASEB J. 2019 Mar;33(3):3912–3921.
   PubMed Web of Science ®Google Scholar
• Cantelmo AR, Conradi LC, Brajic A, et al. Inhibition of the glycolytic activator PFKFB3 in endothelium induces tumor vessel normalization, impairs metastasis, and improves chemotherapy. Cancer Cell. 2016 Dec 12;30(6):968–985.
   PubMed Web of Science ®Google Scholar
• Shirai R, Sato K, Yamashita T, et al. Neopterin Counters Vascular Inflammation and Atherosclerosis. J Am Heart Assoc. 2018;7(3):e007359.
   PubMed Web of Science ®Google Scholar
• Pastorino S, Baldassari S, Ailuno G, et al. Two Novel PET Radiopharmaceuticals for Endothelial Vascular Cell Adhesion Molecule-1 (VCAM-1) Targeting. Pharmaceutics. 2021 6;13(7):Jul.
   Web of Science ®Google Scholar
• Punjabi M, Xu L, Ochoa-Espinosa A, et al. Ultrasound molecular imaging of atherosclerosis with nanobodies: translatable microbubble targeting murine and human VCAM (vascular cell adhesion molecule) 1. Arterioscler Thromb Vasc Biol. 2019 Dec;39(12):2520–2530.
   PubMed Web of Science ®Google Scholar
• Bala G, Crauwels M, Blykers A, et al. Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis - impact of radiochemistry on pharmacokinetics. Biol Chem. 2019 Feb 25;400(3):323–332.
   PubMed Web of Science ®Google Scholar
• Shentu W, Ozawa K, Nguyen TA, et al. Echocardiographic Molecular Imaging of the Effect of Anticytokine Therapy for Atherosclerosis. J Am Soc Echocardiogr. 2021 ;Vol. 34(4):433–442e3.
   PubMed Web of Science ®Google Scholar
• Bayat H, Xu S, Pimentel D, et al. Activation of thromboxane receptor upregulates interleukin (IL)-1beta-induced VCAM-1 expression through JNK signaling. Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):127–134.
   PubMed Web of Science ®Google Scholar
• Shen CK, Huang BR, Yeh WL, et al. Regulatory effects of IL-1beta in the interaction of GBM and tumor-associated monocyte through VCAM-1 and ICAM-1. Eur J Pharmacol. 2021 Aug 15;905:174216.
   PubMed Web of Science ®Google Scholar
• Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018 Jan 11;378(2):158–168.
   PubMed Web of Science ®Google Scholar
• Boutros C, Tarhini A, Routier E, et al. Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination. Nat Rev Clin Oncol. 2016 Aug;13(8):473–486.
   PubMed Web of Science ®Google Scholar
• Lutgens E, Seijkens TTP, et al. Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease. J immunother cancer. 2020; 8(1):e000300.
   PubMed Web of Science ®Google Scholar
• Seijkens TTP, Lutgens E. Cardiovascular oncology: exploring the effects of targeted cancer therapies on atherosclerosis. Curr Opin Lipidol. 2018 Oct;29(5):381–388.
   PubMed Web of Science ®Google Scholar
• Poels K, Mmt VL, Boutros C, et al. Immune checkpoint inhibitor therapy aggravates T cell-driven plaque Inflammation in atherosclerosis. JACC CardioOncol. 2020 Nov;2(4):599–610.
   PubMedGoogle Scholar
• Selewski DT, Shah GV, Segal BM, et al. Natalizumab (Tysabri). AJNR Am J Neuroradiol. 2010 Oct;31(9):1588–1590.
   PubMed Web of Science ®Google Scholar
• Park JG, Ryu SY, Jung IH, et al. Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 2013 Feb;226(2):356–363.
   PubMed Web of Science ®Google Scholar
• Moens AL, Claeys MJ, Timmermans JP, et al. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int J Cardiol. 2005 Apr 20;100(2):179–190.
   PubMed Web of Science ®Google Scholar
• Zhang R, Xu L, Zhang D, et al. Cardioprotection of ginkgolide B on myocardial ischemia/reperfusion-induced inflammatory injury via regulation of A20-NF-kappaB pathway. Front Immunol. 2018;9:2844.
   PubMed Web of Science ®Google Scholar
• Botker HE, Hausenloy D, Andreadou I, et al. Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection. Basic Res Cardiol. 2018 Aug 17;113(5):39.
   PubMed Web of Science ®Google Scholar
• Andreadou I, Cabrera-Fuentes HA, Devaux Y, et al. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. Cardiovasc Res. 2019 Jun 1;115(7):1117–1130.
   PubMed Web of Science ®Google Scholar
• Moran AE, Forouzanfar MH, Roth GA, et al. The global burden of ischemic heart disease in 1990 and 2010: the global burden of disease 2010 study. Circulation. 2014 Apr 8;129(14):1493–1501.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Jacobsen JB, Lash TL, et al. 25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study. BMJ. 2012 Jan;25(344):e356.
   Google Scholar
• Iwamiya T, Matsuura K, Masuda S, et al. Cardiac fibroblast-derived VCAM-1 enhances cardiomyocyte proliferation for fabrication of bioengineered cardiac tissue. Regen Ther. 2016;Jun 4 92–102.
   PubMed Web of Science ®Google Scholar
• Iwamiya T, Segard BD, Matsuoka Y, et al. Human cardiac fibroblasts expressing VCAM1 improve heart function in postinfarct heart failure rat models by stimulating lymphangiogenesis. PLoS One. 2020;15(9):e0237810.
   PubMed Web of Science ®Google Scholar
• Hausenloy DJ, Yellon DM. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev. 2007 Dec;12(3–4):217–234.
   PubMed Web of Science ®Google Scholar
• Hadebe N, Cour M, The LS. SAFE pathway for cardioprotection: is this a promising target? Basic Res Cardiol. 2018 Jan 15;113(2):9.
   PubMed Web of Science ®Google Scholar
• Penna C, Comita S, Tullio F, et al. Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning. Vascul Pharmacol. 2022;Jun 144 106995.
   PubMed Web of Science ®Google Scholar
• Rahimi K, Emdin CA, MacMahon S. The epidemiology of blood pressure and its worldwide management. Circ Res. 2015 Mar 13;116(6):925–936.
   PubMed Web of Science ®Google Scholar
• Virani SS, Alonso A, Aparicio HJ, et al. Heart disease and stroke statistics-2021 update: a report from the American heart association. Circulation. 2021 Feb 23;143(8):e254–e743.
   PubMed Web of Science ®Google Scholar
• Dharmashankar K, Widlansky ME. Vascular endothelial function and hypertension: insights and directions. Curr Hypertens Rep. 2010 Dec;12(6):448–455.
   PubMed Web of Science ®Google Scholar
• Dinh QN, Drummond GR, Sobey CG, et al. Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension. Biomed Res Int. 2014;2014:406960.
   PubMed Web of Science ®Google Scholar
• Li L, Chu Y, Fink GD, et al. Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension. Hypertension. 2003 Nov;42(5):997–1003.
   PubMed Web of Science ®Google Scholar
• Ohanian J, Forman SP, Katzenberg G, et al. Endothelin-1 stimulates small artery VCAM-1 expression through p38MAPK-dependent neutral sphingomyelinase. J Vasc Res. 2012;49(4):353–362.
   PubMed Web of Science ®Google Scholar
• Kim JA, Berliner JA, Nadler JL. Angiotensin II increases monocyte binding to endothelial cells. Biochem Biophys Res Commun. 1996 Sep 24;226(3):862–868.
   PubMed Web of Science ®Google Scholar
• Zhang F, Ren J, Chan K, et al. Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells. Biochem Biophys Res Commun. 2013 Jan 11;430(2):642–646.
   PubMed Web of Science ®Google Scholar
• Liang B, Wang X, Zhang N, et al. Angiotensin-(1-7) attenuates angiotensin II-induced ICAM-1, VCAM-1, and MCP-1 Expression via the MAS Receptor Through Suppression of P38 and NF-kappaB pathways in HUVEC. Cell Physiol Biochem. 2015;35(6):2472–2482.
   PubMedGoogle Scholar
• Srivastava P, Badhwar S, Chandran DS, et al. Imbalance between Angiotensin II - Angiotensin (1-7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension. Diabetes Metab Syndr. 2019 May - Jun;13(3):2061–2068.
   PubMed Web of Science ®Google Scholar
• Chaihongsa N, Maneesai P, Sangartit W, et al. Galangin alleviates vascular dysfunction and remodelling through modulation of the TNF-R1, p-NF-kappaB and VCAM-1 pathways in hypertensive rats. Life Sci. 2021 Nov 15;285:119965.
   PubMed Web of Science ®Google Scholar
• Dikalova AE, Pandey A, Xiao L, et al. Mitochondrial deacetylase sirt3 reduces vascular dysfunction and hypertension while sirt3 depletion in essential hypertension is linked to vascular inflammation and oxidative stress. Circ Res. 2020 Feb 14;126(4):439–452.
   PubMed Web of Science ®Google Scholar
• Chukaeva I, Spiryakina YG, Orlova NV, et al. [Evaluation of inflammatory and endothelial dysfunction’s biomarkers in patients with hypertension at achieving the target blood pressure.]. Klin Lab Diagn. 2018;63(6):337–340.
   PubMedGoogle Scholar
• Tchalla AE, Wellenius GA, Sorond FA, et al. Elevated soluble vascular cell adhesion molecule-1 is associated with cerebrovascular resistance and cognitive function. J Gerontol A Biol Sci Med Sci. 2017 Apr 1;72(4):560–566.
   PubMed Web of Science ®Google Scholar
• Budak E, Madazli R, Aksu MF, et al. Vascular cell adhesion molecule-1 (VCAM-1) and leukocyte activation in pre-eclampsia and eclampsia. Int J Gynaecol Obstet. 1998 Nov;63(2):115–121.
   PubMed Web of Science ®Google Scholar
• Zhang HG, Guo W, Gu HF, et al. Correlation of VCAM-1 expression in serum, cord blood, and placental tissue with gestational hypertension associated with fetal growth restriction in women from Xingtai Hebei, China. Genet Mol Res. 2016;15(3).
   Web of Science ®Google Scholar
• Nzelu D, Nicolaides KH, Kametas NA. First trimester angiogenic and inflammatory factors in women with chronic hypertension and impact of blood pressure control: a case-control study. Bjog. 2021 Dec;128(13):2171–2179.
   PubMed Web of Science ®Google Scholar
• Quintanilha JCF, Liu Y, Etheridge AS, et al. Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance). Angiogenesis. 2022 Feb;25(1):47–55.
   PubMed Web of Science ®Google Scholar
• Marchese ME, Berdnikovs S, Cook-Mills JM. Distinct sites within the vascular cell adhesion molecule-1 (VCAM-1) cytoplasmic domain regulate VCAM-1 activation of calcium fluxes versus Rac1 during leukocyte transendothelial migration. Biochemistry. 2012 Oct 16;51(41):8235–8246.
   PubMed Web of Science ®Google Scholar
• Nettersheim FS, De Vore L, Winkels H, et al. Vaccination in Atherosclerosis. Cells. 2020;9(12):2560.
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International diabetes federation diabetes Atlas, 9(th) edition. Diabetes Res Clin Pract. 2019;Nov 157 107843.
   PubMed Web of Science ®Google Scholar
• Aulicino PL, Siegel JL. Acute injuries of the distal radioulnar joint. Hand Clin. 1991 May;7(2):283–293.
   PubMed Web of Science ®Google Scholar
• Mota RI, Morgan SE, Bahnson EM. Diabetic vasculopathy: macro and microvascular injury. Curr Pathobiol Rep. 2020 Mar;8(1):1–14.
   PubMedGoogle Scholar
• Varona JF, Ortiz-Regalon R, Sanchez-Vera I, et al. Soluble ICAM 1 and VCAM 1 blood levels alert on subclinical atherosclerosis in non smokers with asymptomatic metabolic syndrome. Arch Med Res. 2019 Feb;50(2):20–28.
   PubMed Web of Science ®Google Scholar
• Toblli J, Cao G, Rivas C, et al. Cardiovascular protective effects of nebivolol in Zucker diabetic fatty rats. J Hypertens. 2010 May;28(5):1007–1019.
   PubMed Web of Science ®Google Scholar
• Khan BV, Harrison DG, Olbrych MT, et al. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9114–9119.
   PubMed Web of Science ®Google Scholar
• Sharma A, Sellers S, Stefanovic N, et al. Direct endothelial nitric oxide synthase activation provides atheroprotection in diabetes-accelerated atherosclerosis. Diabetes. 2015 Nov;64(11):3937–3950.
   PubMed Web of Science ®Google Scholar
• Faries PL, Rohan DI, Takahara H, et al. Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg. 2001 Mar;33(3):601–607.
   PubMed Web of Science ®Google Scholar
• VanHeyst KA, Choi SH, Kingsley DT, et al. Ectopic Tumor VCAM-1 Expression in Cancer Metastasis and Therapy Resistance. Cells. 2022;11(23):3922.
   PubMed Web of Science ®Google Scholar
• Sano M, Takahashi R, Ijichi H, et al. Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism. Gut. 2021 Sep;70(9):1713–1723.
   PubMed Web of Science ®Google Scholar
• Meijers WC, Maglione M, Bakker SJL, et al. Heart failure stimulates tumor growth by circulating factors. Circulation. 2018 Aug 14;138(7):678–691.
   PubMed Web of Science ®Google Scholar
• Koelwyn GJ, Aboumsallem JP, Moore KJ, et al. Reverse cardio-oncology: exploring the effects of cardiovascular disease on cancer pathogenesis. J Mol Cell Cardiol. 2022;Feb 163 1–8.
   PubMed Web of Science ®Google Scholar